AR and posterior cortical atrophy: Additionally, other studies suggest that AR-negative or -low PCa cells or clones pre-exist in untreated primary tumors and they tend to become accentuated in metastatic foci of the CRPC patients, stressing a role of AR-independent mechanisms in therapy resistance and disease progression20–23.